Quest Partners LLC bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,128 shares of the biopharmaceutical company’s stock, valued at approximately $991,000. Other large investors have also recently […]